Key Takeaways for Colgate-Palmolive Stock as of August 2026
- Broad Beat Across the Board: Colgate-Palmolive posted $5.36B in Q2 revenue, a 0.06% beat versus Street, while adjusted EPS of $0.99 topped estimates by 4.53% and climbed 7.61% YoY.
- Margin Guide Raised: Management lifted its full-year gross margin outlook to roughly flat.
- Cash Flow Inflection: Free cash flow hit $867M, beating Street’s $308.70M estimate by 180.86% and marking the quarter’s sharpest positive surprise.
- US Shipments Lag Consumption: CEO Noel Wallace flagged North America shipments down 3% against roughly flat consumption, pointing to retailer inventory destocking rather than weaker demand.
Dig into Colgate-Palmolive’s full Q2 numbers on TIKR for free →
A Cash Flow Surge Can’t Fully Cover Colgate-Palmolive’s US Cracks
Colgate-Palmolive (CL) closed its second quarter of fiscal 2026 on June 30 with revenue of $5.36 billion, edging Street estimates by just 0.06% but climbing 4.91% year over year. Adjusted earnings per share reached $0.99, a beat of 4.53% versus the $0.95 consensus and a 7.61% jump from the $0.92 posted a year earlier. The headline number that stood out was free cash flow: $867 million, more than double the $308.70 million analysts had modeled, a 180.86% surprise that reset expectations for the balance sheet heading into the back half of the year.
That strength did not extend to the bottom line’s GAAP measure. Reported EPS of $0.86 missed the $0.94 estimate by 8.39% and fell 5.49% from the prior year, even as adjusted EPS climbed. The gap signals one-time items working against the headline print, a reminder that Colgate-Palmolive’s underlying operating momentum runs stronger than the GAAP number alone suggests.
Gross margin told the more encouraging story, rising 100 basis points year over year and 90 basis points from the first quarter, with only a modest lift from tariff refunds. CFO Stan Sutula addressed the source of that strength directly on the Q2 earnings call: “We are very pleased with the margin performance here in Q2. And it was multifaceted with good RGM, good productivity, the pricing, the mix, a very, very strong performance here by the teams.” That execution gave management enough confidence to raise its full-year gross margin guidance to roughly flat, up from a prior expectation of decline.
North America told a different story. Shipments fell 3% even as consumption held closer to flat, a gap Wallace attributed to retailers trimming inventory after May’s category slowdown tied to spiking gasoline prices. Categories rebounded in June and July but stayed below historical levels, and management responded by stepping up advertising, addressing select price gaps against competitors, and accelerating premium innovation like Optic White Pro Series.
Emerging markets carried the quarter instead. Latin America grew organic sales 5%, with Brazil up high single digits on both pricing and volume, while Greater China rose mid-single digits despite a category management estimates is down 1% to 2%. Yet Colgate-Palmolive held the low end of its organic sales growth guidance steady rather than raising it, even after running 2.6% year to date, choosing caution over the uncertainty still hanging over oil prices and consumer confidence.
See how Colgate-Palmolive’s cash flow surge and US destocking play out on TIKR for free →
TIKR Values Colgate-Palmolive Stock at $123, Banking on Margin Discipline
TIKR’s mid-case model values Colgate-Palmolive stock at $123 by December 2030, implying a 35% total return from the current price of $91, or 7% annualized over 4.4 years.
That return profile places Colgate-Palmolive stock in line with a steady, single-digit compounder rather than a high-growth name, consistent with a company whose growth engine runs through emerging markets and margin discipline rather than volume acceleration.
The target extends the dynamics already visible in the second quarter: gross margin expansion, emerging market growth, and a free cash flow beat. Colgate-Palmolive stock’s climb to $123 runs through continued execution abroad and margin discipline at home, not through an immediate North America turnaround.
Colgate-Palmolive stock trades well below TIKR’s $123 target. See the full valuation model on TIKR for free →
Should You Invest in Colgate-Palmolive Company?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Colgate-Palmolive stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Colgate-Palmolive Company alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze CL stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
